Page 5 - Franklinm Berger News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Franklinm berger. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Franklinm Berger Today - Breaking & Trending Today

BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights


BELLUS Health Reports First Quarter 2021 Financial Results and Business Highlights
Phase 2b SOOTHE and Phase 2a BLUEPRINT clinical trials on track, with topline results expected Q4 2021 – – Ended quarter with US$81.9 million in cash, cash equivalents and short-term investments; current cash position expected to be sufficient to fund operating plan until end of 2022 – BELLUS Health Inc. a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic …
– Phase 2b SOOTHE and Phase 2a BLUEPRINT clinical trials on track, with topline results expected Q4 2021 –
– Ended quarter with US$81.9 million in cash, cash equivalents and short-term investments; current cash position expected to be sufficient to fund operating plan until end of 2022 – ....

United States , Danny Matthews , Youssefl Bennani , Francesco Bellini , Pierre Larochelle , Franklinm Berger , Roberto Bellini , Clarissa Desjardins , Joseph Rus , William Mezzanotte , Exchange Commission , Development Expenses , Directors Of The Company , Health Inc , Chief Executive Officer , Administrative Expenses , Finance Income , Announces Election , Annual Meeting , Management Information Circular , Securities Litigation Reform Act , Annual Information Form , United States Securities , Annual Report , Investor Relations , ஒன்றுபட்டது மாநிலங்களில் ,

ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders


0.10%
At the Meeting, the Shareholders also approved: (i) the re-appointment of Davidson & Company LLP, Chartered Professional Accountants, as auditors of the Company; (ii) the Company s omnibus incentive plan; (iii) an amendment to the Company s existing stock option plan (the
Amended Option Plan ) and the previous grant of stock options exercisable thereunder; and (iv) an amendment to the Company s articles.
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
About Prostate Cancer ....

United States , British Columbia , Scott Requadt , Alex Martin , Marella Thorell , Franklinm Berger , Richardm Glickman , Gary Sollis , Sandy Zweifach , Davidr Parkinson , Company The Shareholders , Pharma Inc , Davidson Company , Annual General Meeting , Ari Brettman , Chartered Professional Accountants , Essa Pharma Inc , ஒன்றுபட்டது மாநிலங்களில் , பிரிட்டிஷ் கொலம்பியா , அலெக்ஸ் மார்டின் , மணல் ஜுவெபச் , நிறுவனம் தி பங்குதாரர்கள் , பார்மா இன்க் , டேவிட்சன் நிறுவனம் , ஆண்டு ஜநரல் சந்தித்தல் , பட்டய ப்ரொஃபெஶநல் கணக்காளர்கள் ,